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Editorial  
 
Towards a better understanding of the size and burden and cost of brain 
disorders in Europe  
 
 
This special issue was prepared within the framework of the European College of 
Neuropsychopharmacology (ECNP) Task Force on “Size and Burden of Mental Disorders in 
Europe”. The core aim of the Task Force was to describe the prevalence and the burden of 
treated and untreated mental disorders in all European member states and to highlight needs 
for further research. Ten state-of-theart epidemiological papers summarize the outcome of this 
project, making an attempt to provide for the first time ever prevalence estimates for a wide 
range of mental disorders, as well as for dementia and Parkinson’s disease in 28 European 
countries. These data also provide input for the European Brain Council (EBC, 
http://www.ebc-eurobrain. net) Initiative “Cost of Disorders of the Brain in Europe” aiming at 
estimating the cost of major classes of mental, neurological and neurosurgical disorders and 
conditions in Europe.  
 
In an unprecedented concerted scientific and organizational effort, several interdisciplinary 
task forces involving researchers, clinicians, patient organizations, epidemiologists, 
economists, psychiatrists, psychologists, neurologists and neurosurgeons from over 21 
European countries worked together to reach a consensus on what we know about the size, 
burden and cost of “disorders of the brain” in each European country and–ultimately–in 
Europe as a whole. For a total of 20 mental and neurological disorders, most of which are 
dealt with in this issue, systematic reviews of epidemiological studies in EU countries were 
conducted. Additionally, searches and inquiries were conducted to identify smaller and 
regional studies as well as those not covered by the major literature search systems. Further 
reanalyses of existing data sets were performed, and ultimately the results from each of these 
iterative steps were circulated among all contributors and country-specific experts.  
 
Under the interdisciplinary umbrella of the EBC, the including of various neurological and 
neurosurgical conditions could ensure a broader coverage of disorders of the brain. 
Altogether, the project provided a remarkably broad interdisciplinary and European platform 
of disciplines and professionals from many countries that have rarely collaborated before in 
such a challenging task. The methods, procedures and the outcome of this process to evaluate 
mental disorders, dementia and Parkinson’s disease are summarized in this special issue. 
Additional publications from this project are published elsewhere (Andlin-Sobocki et al., 
2005).  
 
According to the overall findings, over 80 million women and men of all ages in the EU are 
estimated to suffer from mental disorders or more broadly “disorders of the brain”. Even 
though only a restricted range of all existing mental and neurological disorders from the ICD- 
10 or the DSM-IV was considered, there is clear evidence that more than one third of the 
adult EU population is or has been affected by at least one disorder in the past year, or 50% of 
the EU population, respectively, if lifetime risk is considered. The enormous degree of burden 
and suffering that can be associated with these disorders, particularly if no treatment and 
appropriate care is provided, becomes self-evident. Mental disorders such as schizophrenia, 
major depression and panic disorder can start as early as in childhood and adolescence. They 
typically have adverse effects on school and academic career, social functioning and somatic 
health throughout the life span, and are associated with frequently immense suffering for the 
families, partners and friends. They are also a major cause of premature mortality, either 
caused by suicide or by the effects of complications arising from associated risk factors. As 
the result of the high prevalence of mental disorders, combined with an early onset and an 
unfavourable long-term course of the illness, the total burden associated with mental disorders 
is immense. For the greater European Union, the World Health Organisation estimated that of 
the total burden associated with all medical disorders, over 25% of all “Disability Adjusted 
Life Years lost” (DALYs) are accounted for by a small number of mental disorders 
considered. Considering a broader range of brain diseases, Olesen and Leonardi (2003) have 
suggested even higher estimates of up to 35%.  
 
Such crude projections are undoubtedly of great political and public health interest. However, 
from a scientific perspective, they are clearly incomplete and unsatisfactory, and they do 
require further evidence and support through clinical and epidemiological data in order to 
provide guidance for future action. Burden of disease estimates are neither very informative 
with regard to single disorders, for example because of the well documented high degree of 
age-dependent comorbidity, nor could they be generalized to all EU countries, for example 
because of different sociodemographic and socioeconomic situations. In addition, indicators 
like DALY estimates tell us little about the met and unmet needs for treatment or about the 
costs associated with different diseases and in what part of the health care sector these occur.  
 
The ECNP/EBC project initiative “Size and Burden of Mental Disorders” with its 
epidemiological and health economic extensions is undoubtedly a significant step forward 
towards a much needed European data base regarding prevalence and cost of mental 
disorders. Based on the prevalence and burden data presented in this special issue, the 
project’s health economic estimates for the year 2004 (Table 1) reveal that mental disorders 
are associated with immense total costs of over 290 billion Euros. The vast majority of these 
costs are not related to treatment or other health care expenditure, but rather to the indirect 
costs. Including major neurological and neurosurgical conditions, the cost burden of all brain 
disorders considered here even amounts to over 387 billion in the year 2004 and for various 
reasons these numbers must be regarded as conservative figures.  
 
It seems fair to state that most policymakers as well as the public have so far not only 
underestimated the true size and burden and the cost associated with mental disorders, but 
might be even unaware of the existence and the significance of many disorders of the brain. 
The size and the immense cost implications of mental disorders and their further increase due 
to an aging EU-population clearly call for concerted action on various levels; from 
substantially increased funding of basic and clinical research to better training and educational 
programs.  
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